221 related articles for article (PubMed ID: 30013189)
1. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1.
Chen WH; Cai MY; Zhang JX; Wang FW; Tang LQ; Liao YJ; Jin XH; Wang CY; Guo L; Jiang YG; Ren CP; Mai HQ; Zeng MS; Kung HF; Qian CN; Xie D
Oncogene; 2018 Nov; 37(48):6243-6258. PubMed ID: 30013189
[TBL] [Abstract][Full Text] [Related]
2. MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo.
Song Q; Zhang H; Wang M; Song W; Ying M; Fang Y; Li Y; Chao Y; Zhu X
J Exp Clin Cancer Res; 2013 Aug; 32(1):54. PubMed ID: 23941622
[TBL] [Abstract][Full Text] [Related]
3. miR-143 inhibits proliferation and metastasis of nasopharyngeal carcinoma cells via targeting FMNL1 based on clinical and radiologic findings.
Cui F; Ji Y; Wang M; Gao F; Li Y; Li X
J Cell Biochem; 2019 Oct; 120(10):16427-16434. PubMed ID: 31001854
[TBL] [Abstract][Full Text] [Related]
4. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.
Zhu W; Cai MY; Tong ZT; Dong SS; Mai SJ; Liao YJ; Bian XW; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
Gut; 2012 Apr; 61(4):562-75. PubMed ID: 21813470
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
Qian W; Ren Z; Lu X
Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
[TBL] [Abstract][Full Text] [Related]
7. MTA1 contributes to actin cytoskeleton reorganization and metastasis of nasopharyngeal carcinoma by modulating Rho GTPases and Hedgehog signaling.
Song Q; Li Y; Zheng X; Fang Y; Chao Y; Yao K; Zhu X
Int J Biochem Cell Biol; 2013 Jul; 45(7):1439-46. PubMed ID: 23618874
[TBL] [Abstract][Full Text] [Related]
8. MiR-30e-5p inhibits the migration and invasion of nasopharyngeal carcinoma via regulating the expression of MTA1.
Hu W; Yao W; Li H; Chen L
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32458989
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction.
Lin Z; Wan X; Jiang R; Deng L; Gao Y; Tang J; Yang Y; Zhao W; Yan X; Yao K; Sun B; Chen Y
J Virol; 2014 Oct; 88(20):11872-85. PubMed ID: 25100829
[TBL] [Abstract][Full Text] [Related]
10. MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.
Deng L; Tang J; Yang H; Cheng C; Lu S; Jiang R; Sun B
Oncogene; 2017 Jul; 36(28):3976-3985. PubMed ID: 28288133
[TBL] [Abstract][Full Text] [Related]
11. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
Wang G; Wang S; Li C
Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
[TBL] [Abstract][Full Text] [Related]
12. MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties.
Feng X; Zhang Q; Xia S; Xia B; Zhang Y; Deng X; Su W; Huang J
Mol Cells; 2014 Sep; 37(9):699-704. PubMed ID: 25245523
[TBL] [Abstract][Full Text] [Related]
13. Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.
Bian W; Zhang H; Tang M; Zhang S; Wang L; Liu L; Wang W
Cell Physiol Biochem; 2018; 51(5):2065-2072. PubMed ID: 30522116
[TBL] [Abstract][Full Text] [Related]
14. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
[TBL] [Abstract][Full Text] [Related]
15. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
16. MTA1 promotes viability and motility in nasopharyngeal carcinoma by modulating IQGAP1 expression.
Lu B; Lian R; Wu Z; Miao W; Li X; Li J; Shi Y; Yu W
J Cell Biochem; 2018 May; 119(5):3864-3872. PubMed ID: 29125886
[TBL] [Abstract][Full Text] [Related]
17. FMNL1 down-regulation suppresses bone metastasis through reducing TGF-β1 expression in non-small cell lung cancer (NSCLC).
Yang XY; Liao JJ; Xue WR
Biomed Pharmacother; 2019 Sep; 117():109126. PubMed ID: 31387165
[TBL] [Abstract][Full Text] [Related]
18. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
Cui Z; Zhao Y
BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
[TBL] [Abstract][Full Text] [Related]
19. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression levels of MTA1 and RECK in nasopharyngeal carcinoma: association with metastasis, recurrence, and prognosis.
Deng YF; Zhou DN; Ye CS; Zeng L; Yin P
Ann Otol Rhinol Laryngol; 2012 Jul; 121(7):457-65. PubMed ID: 22844865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
